Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

SEATTLE, June 25, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today issued the following statement regarding the notification of the U.S. Food and Drug Administration (the "FDA") partial clinical hold on tosedostat (IND 075503), the Company's aminopeptidase inhibitor under development for the treatment of blood-related cancers, that is being studied in an investigator-sponsored trial and not by CTI. CTI's primary development programs are the ongoing Phase 3 trial of pacritinib, the Company's JAK2/FLT3 inhibitor being evaluated for patients with myelofibrosis, and the post-approval commitment study of PIXUVRI® (pixantrone).

This is a partial clinical hold of only part of the clinical work requested under the investigational new drug ("IND") application. Under a partial clinical hold, although a specific protocol or part of a protocol is not allowed to proceed, other parts of such protocol or other protocols are allowed to proceed under the IND. With this partial clinical hold, the Company may not enter new patients onto any of the ongoing tosedostat protocols until agreement is reached with the FDA.

After a study has been placed on partial clinical hold, the sponsor provides additional information and discusses the adverse event with the FDA to understand whether or not it was associated with the drug or due to another cause. The Company has begun work to comply with the FDA request and expects to be able to submit these data to the FDA in the coming weeks. For additional information, please refer to the Current Report on Form 8-K filed by the Company on June 24, 2013.

Recent Tosedostat Publication
In March 2013, Lancet Oncology published results from the OPAL Phase 2 study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML). The trial showed that once-daily oral tosedostat resulted in a disease contro
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)...  Dedicated to promoting wellness and giving back to ... the purple pledge in support of Alzheimer,s & Brain-Awareness ... a time to shine a purple light for the ... people in our community who are affected by Alzheimer,s. ... and helps mobilize friends, family members, neighbors and coworkers ...
(Date:7/7/2015)... 7. Juli 2015 BioClinica®, Inc ... klinische Studien, gab heute bekannt, dass es mit ... bei Gewinnung und Erhalt von Patienten übernommen hat. ... MediciGlobal , Ltd. und Access to Patients, LLC. ... Dienst zum Auffinden von Patienten, die für die ...
(Date:7/7/2015)... California and BANGALORE , ... , a global technology provider of innovative clinical trial ... Reports, (Industry Standard Research Reports) recent publication named " ... Provider Performance (2015) ". ISR Reports is one of ... pharmaceutical industry, and this report evaluated 22 EDC and ...
Breaking Medicine Technology:Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... , , PRINCETON, N.J., Jan. 8 Pharmasset, Inc. ... 28th Annual JPMorgan Healthcare Conference being held from January 11 to ... Schaefer Price, Pharmasset,s President and Chief Executive Officer, will provide an ... 2010 at 2:00 PM (PT). , To access a simultaneous webcast ...
... Mylan Inc. (Nasdaq: MYL ) today announced that, in ... term-loan borrowings that were due in 2011. As a result, ... , Mylan Chairman and CEO Robert J. Coury said: "The ... continued strong operating cash flows and our continuing effort to ...
Cached Medicine Technology:Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference 2Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference 3
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation centers ... to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and its ... are committed to making sure patients have access to cannabis as a viable ...
(Date:7/7/2015)... , ... July 07, 2015 , ... At the end of June Pacific Prime Renewals ... ‘go green’ . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not ... , On this initiative Cotton explained, “We send anything between 300 and 600 pieces ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune ... for its patient community using its IDF ePHR, an electronic personal health record ... diseases (PI) to easily track their health information, including symptoms, diagnoses, medications, infusions ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Parents and guardians ... by A Forever Recovery, an open-ended holistic treatment center for drug and alcohol abuse ... Drug Use and HIV Research has shown a significant increase in the “club drug” ...
(Date:7/7/2015)... ... 2015 , ... Georgia Partnership for TeleHealth (GPT), ... announces the launch of the first ambulance telemedicine program in the state, which ... new program will not only provide more immediate patient care, but will also ...
Breaking Medicine News(10 mins):Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2
... Association Urges Parents to Protect Their Preteens and Teens through ... as a pleasant day at the beach quickly turned into ... portions of his feet and suffering organ failure. Lynn Bozof,s ... a terrible headache, and within hours was admitted to the ...
... Color Touch Screen GPS Rangefinder IntroducedHOUSTON, Jan. 27 ... , its revolutionary new touch screen GPS rangefinder, ... OnPar is the first hand held color ... golfers the ultimate user experience. It,s like ...
... Product in New Bubble Gum Flavor for Ages Two ... McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., today ... Syrup, a new sugar-free, dye-free bubble gum flavor product ... known as upper respiratory allergies, in children ages two ...
... Gupta,s Commitment to Enriching Quality of Life Through Exercise ... Council on Exercise (ACE), America,s leading authority on fitness ... training organizations in the world, today announced its support ... chief medical correspondent for the health and medical unit ...
... 27 HCA Healthcare announces the following Webcast:, What: ... @ 10:00 EST, Where: http://www.videonewswire.com/event.asp?id=55052 , ... the web at the, ... Healthcare, +1-615 ...
... Network Power, a business of Emerson and the global leader ... DA12-M series wall mount switching adapters, designed specifically for medical ... ... Carlsbad, CA (PRWEB) January 27, 2009 -- Emerson ...
Cached Medicine News:Health News:Video: Late Winter/Early Spring is Meningitis Peak Season: Is Your Preteen or Teen at Risk? 2Health News:OnPar(R) Redefines Golf Experience 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 3Health News:American Council on Exercise (ACE) Endorses Appointment of Dr. Sanjay Gupta as Surgeon General of the United States 2Health News:Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications 2Health News:Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: